Modified Si–Jun–Zi–Tang Attenuates Airway Inflammation in a Murine Model of Chronic Asthma by Inhibiting Teff Cells via the mTORC1 Pathway

Modified Si–Jun–Zi–Tang Attenuates Airway Inflammation in a Murine Model of Chronic Asthma by Inhibiting Teff Cells via the mTORC1 Pathway

Background: Modified Si–Jun–Zi–Tang (MSJZT), a multi-herb formulation, is frequently used in traditional Chinese medicine for patients during the remission stage of asthma. However, the pharmacological basis underlying the effects of MSJZT on asthma has yet to be elucidated. This study aims at evalu...

Full description

Bibliographic Details
Main Authors: Hualiang Jin, Cui Cai, Bei Li, Weizhong Jin, Junbo Xia, Limin Wang, Shenglin Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Pharmacology
Subjects:
modified Si–Jun–Zi–Tang
asthma
airway inflammation
T effector lymphocytes
mTORC1
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00161/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00161/full

Similar Items